Coherus Oncology, Inc. Other Comprehensive Income (Loss), Net of Tax
Coherus Oncology, Inc. (CHRS) reported Other Comprehensive Income (Loss), Net of Tax of -$13.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- Coherus Oncology, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$13.00K.
- Coherus Oncology, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$73.00K.
- Coherus Oncology, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $72.00K.
- Coherus Oncology, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-09-30 was -$3.00K, a 109.38% decline year-over-year.
- Coherus Oncology, Inc. other comprehensive income (loss), net of tax for fiscal 2025 was $80.00K.
- Coherus Oncology, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was -$27.00K.
- Coherus Oncology, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was $21.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.00K 10-Q · filed 2026-08-05 | -$86.00K derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | -$73.00K 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $80.00K 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $72.00K 10-Q · filed 2025-11-06 | |||
| 2024-12-31 | -$27.00K 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$3.00K 10-Q · filed 2025-11-06 | |||
| 2024-03-31 | -$24.00K 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $1.00K 8-K · filed 2025-11-13 | |||
| 2023-09-30 | $32.00K 10-Q · filed 2024-11-06 | $13.00K derived: sum of 2 quarters · filed 2024-11-06 | -$16.00K derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | -$19.00K 10-Q · filed 2024-11-06 | -$48.00K derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | -$29.00K 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $21.00K 10-K · filed 2025-03-17 | |||
| 2022-06-30 | $2.00K 10-Q · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | ||
| 2022-03-31 | -$2.00K 10-Q · filed 2023-11-06 | |||
| 2021-09-30 | -$6.00K 10-Q · filed 2022-11-08 | $34.00K derived: sum of 2 quarters · filed 2022-11-08 | -$3.00K derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $40.00K 10-Q · filed 2022-11-08 | $3.00K derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | -$37.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |